Frontotemporal dementia

The Lancet

Volumn 386, Issue 10004, 2015, Pages 1672-1682

  Bang, Jee ^a   Spina, Salvatore ^a   Miller, Bruce L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ATYPICAL ANTIPSYCHOTIC AGENT; BEPRIDIL; CHLOROQUINE; CHOLINESTERASE INHIBITOR; HISTONE DEACETYLASE INHIBITOR; NIMODIPINE; PROGRANULIN; SEROTONIN UPTAKE INHIBITOR; TAR DNA BINDING PROTEIN;

AGGRESSION; ALZHEIMER DISEASE; ANXIETY; APATHY; APRAXIA OF SPEECH; ARTICLE; CLINICAL FEATURE; DEGENERATIVE DISEASE; DIFFERENTIAL DIAGNOSIS; DYSARTHRIA; DYSPHAGIA; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL DEMENTIA; HUMAN; INCONTINENCE; IRRITABILITY; LIBIDO DISORDER; MOTOR NEURON DISEASE; MUSCLE ATROPHY; MUSCLE WEAKNESS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PERSONALITY DISORDER; PHENOTYPE; PREVALENCE; PRIMARY PROGRESSIVE APHASIA; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SEMANTIC DEMENTIA; SLEEP DISORDER; SPEECH AND LANGUAGE ASSESSMENT; STUDY; TEMPORAL CORTEX; ADULT; AGED; APHASIA; DIAGNOSTIC IMAGING; GENETICS; MENTAL DISORDERS; MIDDLE AGED; NEURODEGENERATIVE DISEASES; PATHOLOGY;

ADULT; AGED; ALZHEIMER DISEASE; APHASIA; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; MENTAL DISORDERS; MIDDLE AGED; MOTOR NEURON DISEASE; NEURODEGENERATIVE DISEASES;

EID: 84945340060     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)00461-4     Document Type: Review

References (83)

1. RT Vieira, L Caixeta, S Machado et al. Epidemiology of early-onset dementia: a review of the literature Clin Pract Epidemiol Ment Health 9 2013 88 95
2. A Pick Über die Beziehungen der senilen Hirnatrophie zur Aphasie Prager Med Wochenschr 17 1892 165 167
3. A Alzheimer Über eigenartige Krankheitsfälle der späteren Alters Z Gesamte Neurol Psychiatr 4 1911 356 385
4. MM Mesulam Primary progressive aphasia Ann Neurol 49 2001 425 432
5. K Rascovsky, JR Hodges, D Knopman et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia Brain 134 2011 2456 2477
6. ML Gorno-Tempini, AE Hillis, S Weintraub et al. Classification of primary progressive aphasia and its variants Neurology 76 2011 1006 1014
7. WHO Dementia fact sheet http://www.who.int/mediacentre/factsheets/fs362/en/ March, 2015 (accessed Nov 10, 2014).
8. DS Knopman, RO Roberts Estimating the number of persons with frontotemporal lobar degeneration in the US population J Mol Neurosci 45 2011 330 335
9. MA Lambert, H Bickel, M Prince et al. Estimating the burden of early onset dementia; systematic review of disease prevalence Eur J Neurol 21 2014 563 569
10. JR Hodges, R Davies, J Xuereb, J Kril, G Halliday Survival in frontotemporal dementia Neurology 61 2003 349 354
11. BL Miller, BF Boeve The behavioral neurology of dementia 2009 Cambridge University Press Cambridge, UK and New York, NY, USA
12. RR Davies, CM Kipps, J Mitchell, JJ Kril, GM Halliday, JR Hodges Progression in frontotemporal dementia: identifying a benign behavioral variant by magnetic resonance imaging Arch Neurol 63 2006 1627 1631
13. CM Kipps, JR Hodges, M Hornberger Nonprogressive behavioural frontotemporal dementia: recent developments and clinical implications of the 'bvFTD phenocopy syndrome' Curr Opin Neurol 23 2010 628 632
14. BK Khan, JS Yokoyama, LT Takada et al. Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9orf72 hexanucleotide expansion J Neurol Neurosurg Psychiatry 83 2012 358 364
15. D Neary, JS Snowden, L Gustafson et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria Neurology 51 1998 1546 1554
16. WW Seeley, AM Bauer, BL Miller et al. The natural history of temporal variant frontotemporal dementia Neurology 64 2005 1384 1390
17. SA Thompson, K Patterson, JR Hodges Left/right asymmetry of atrophy in semantic dementia: behavioral-cognitive implications Neurology 61 2003 1196 1203
18. JR Burrell, MC Kiernan, S Vucic, JR Hodges Motor neuron dysfunction in frontotemporal dementia Brain 134 2011 2582 2594
19. I Le Ber, E Guedj, A Gabelle the French research network on FTD/FTD-MND Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia Brain 129 2006 3051 3065
20. I Litvan, Y Agid, D Calne et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop Neurology 47 1996 1 9
21. JD Woolley, BK Khan, NK Murthy, BL Miller, KP Rankin The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease J Clin Psychiatry 72 2011 126 133
22. D Galimberti, A Reif, B Dell'osso et al. C9orf72 hexanucleotide repeat expansion is a rare cause of schizophrenia Neurobiol Aging 35 2014 1214 e7-1214. e10.
23. D Galimberti, A Reif, B Dell'Osso et al. C9orf72 hexanucleotide repeat expansion as a rare cause of bipolar disorder Bipolar Disord 16 2014 448 449
24. D Galimberti, C Fenoglio, M Serpente et al. Autosomal dominant frontotemporal lobar degeneration due to the C9orf72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation Biol Psychiatry 74 2013 384 391
25. DO Claassen, JE Parisi, C Giannini, BF Boeve, DW Dickson, KA Josephs Frontotemporal dementia mimicking dementia with Lewy bodies Cogn Behav Neurol 21 2008 157 163
26. R Perri, M Monaco, L Fadda, C Caltagirone, GA Carlesimo Neuropsychological correlates of behavioral symptoms in Alzheimer's disease, frontal variant of frontotemporal, subcortical vascular, and lewy body dementias: a comparative study J Alzheimers Dis 39 2014 669 677
27. HJ Rosen, ML Gorno-Tempini, WP Goldman et al. Patterns of brain atrophy in frontotemporal dementia and semantic dementia Neurology 58 2002 198 208
28. Y Zhang, N Schuff, AT Du et al. White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI Brain 132 2009 2579 2592
29. ME Raichle, AM MacLeod, AZ Snyder, WJ Powers, DA Gusnard, GL Shulman A default mode of brain function Proc Natl Acad Sci USA 98 2001 676 682
30. RL Buckner, AZ Snyder, BJ Shannon et al. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory J Neurosci 25 2005 7709 7717
31. WW Seeley, RK Crawford, J Zhou, BL Miller, MD Greicius Neurodegenerative diseases target large-scale human brain networks Neuron 62 2009 42 52
32. M Maruyama, H Shimada, T Suhara et al. Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls Neuron 79 2013 1094 1108
33. IR Mackenzie, M Neumann, EH Bigio et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update Acta Neuropathol 119 2010 1 4
34. WW Seeley, R Crawford, K Rascovsky et al. Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia Arch Neurol 65 2008 249 255
35. EJ Kim, M Sidhu, SE Gaus et al. Selective frontoinsular von Economo neuron and fork cell loss in early behavioral variant frontotemporal dementia Cereb Cortex 22 2012 251 259
36. A Baborie, TD Griffiths, E Jaros et al. Pathological correlates of frontotemporal lobar degeneration in the elderly Acta Neuropathol 121 2011 365 371
37. KA Josephs, JR Hodges, JS Snowden et al. Neuropathological background of phenotypical variability in frontotemporal dementia Acta Neuropathol 122 2011 137 153
38. A Sieben, T Van Langenhove, S Engelborghs et al. The genetics and neuropathology of frontotemporal lobar degeneration Acta Neuropathol 124 2012 353 372
39. WW Barker, CA Luis, A Kashuba et al. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank Alzheimer Dis Assoc Disord 16 2002 203 212
40. DW Dickson, JJ Hauw, Y Agid, I Litvan Progressive Supranuclear Palsy and Corticobasal Degeneration 2011 Wiley-Blackwell Hoboken, NJ
41. JJ Rebeiz, EH Kolodny, EP Richardson Jr Corticodentatonigral degeneration with neuronal achromasia Arch Neurol 18 1968 20 33
42. AL Boxer, MD Geschwind, N Belfor et al. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy Arch Neurol 63 2006 81 86
43. IR Mackenzie, M Neumann, A Baborie et al. A harmonized classification system for FTLD-TDP pathology Acta Neuropathol 122 2011 111 113
44. JD Rohrer, F Geser, J Zhou et al. TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia Neurology 75 2010 2204 2211
45. IR Mackenzie, DG Munoz, H Kusaka et al. Distinct pathological subtypes of FTLD-FUS Acta Neuropathol 121 2011 207 218
46. IR Mackenzie, D Foti, J Woulfe, TA Hurwitz Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions Brain 131 2008 1282 1293
47. JD Rohrer, R Guerreiro, J Vandrovcova et al. The heritability and genetics of frontotemporal lobar degeneration Neurology 73 2009 1451 1456
48. I Le Ber Genetics of frontotemporal lobar degeneration: an up-date and diagnosis algorithm Rev Neurol 169 2013 811 819
49. JS Goldman, R Rademakers, ED Huey et al. An algorithm for genetic testing of frontotemporal lobar degeneration Neurology 76 2011 475 483
50. M DeJesus-Hernandez, IR Mackenzie, BF Boeve et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9orf72 causes chromosome 9p-linked FTD and ALS Neuron 72 2011 245 256
51. R Rademakers, M Neumann, IR Mackenzie Advances in understanding the molecular basis of frontotemporal dementia Nat Rev Neurol 8 2012 423 434
52. AE Renton, E Majounie, A Waite the ITALSGEN Consortium A hexanucleotide repeat expansion in C9orf72 is the cause of chromosome 9p21-linked ALS-FTD Neuron 72 2011 257 268
53. M Hutton, CL Lendon, P Rizzu et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17 Nature 393 1998 702 705
54. I Gijselinck, C Van Broeckhoven, M Cruts Granulin mutations associated with frontotemporal lobar degeneration and related disorders: an update Hum Mutat 29 2008 1373 1386
55. SS Shankaran, A Capell, AT Hruscha et al. Missense mutations in the progranulin gene linked to frontotemporal lobar degeneration with ubiquitin-immunoreactive inclusions reduce progranulin production and secretion J Biol Chem 283 2008 1744 1753
56. H Toh, BP Chitramuthu, HP Bennett, A Bateman Structure, function, and mechanism of progranulin; the brain and beyond J Mol Neurosci 45 2011 538 548
57. W Tang, Y Lu, QY Tian et al. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice Science 332 2011 478 484
58. ZA Miller, KP Rankin, NR Graff-Radford et al. TDP-43 frontotemporal lobar degeneration and autoimmune disease J Neurol Neurosurg Psychiatry 84 2013 956 962
59. S Lattante, GA Rouleau, E Kabashi TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update Hum Mutat 34 2013 812 826
60. TF Gendron, KF Bieniek, YJ Zhang et al. Antisense transcripts of the expanded C9orf72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS Acta Neuropathol 126 2013 829 844
61. S Mizielinska, T Lashley, FE Norona et al. C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci Acta Neuropathol 126 2013 845 857
62. K Mori, SM Weng, T Arzberger et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS Science 339 2013 1335 1338
63. MA Farg, V Sundaramoorthy, JM Sultana et al. C9orf72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking Hum Mol Genet 23 2014 3579 3595
64. IR Mackenzie, P Frick, M Neumann The neuropathology associated with repeat expansions in the C9orf72 gene Acta Neuropathol 127 2014 347 357
65. JL Whitwell, SD Weigand, BF Boeve et al. Neuroimaging signatures of frontotemporal dementia genetics: C9orf72, tau, progranulin and sporadics Brain 135 2012 794 806
66. JD Rohrer, GR Ridgway, M Modat et al. Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations Neuroimage 53 2010 1070 1076
67. M Cruts, J Theuns, C Van Broeckhoven Locus-specific mutation databases for neurodegenerative brain diseases Hum Mutat 33 2012 1340 1344
68. Y Liu, JT Yu, Y Zong, J Zhou, L Tan C9orf72 mutations in neurodegenerative diseases Mol Neurobiol 49 2014 386 398
69. A Nalbandian, S Donkervoort, E Dec et al. The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis J Mol Neurosci 45 2011 522 531
70. IE Holm, E Englund, IR Mackenzie, P Johannsen, AM Isaacs A reassessment of the neuropathology of frontotemporal dementia linked to chromosome 3 J Neuropathol Exp Neurol 66 2007 884 891
71. Boxer A. Establishing therapeutic efficacy in familial frontotemporal degeneration; San Francisco, CA, USA; Nov 14-15, 2013.
72. F Lebert, W Stekke, C Hasenbroekx, F Pasquier Frontotemporal dementia: a randomised, controlled trial with trazodone Dement Geriatr Cogn Disord 17 2004 355 359
73. L Asmal, SJ Flegar, J Wang, C Rummel-Kluge, K Komossa, S Leucht Quetiapine versus other atypical antipsychotics for schizophrenia Cochrane Database Syst Rev 11 2013 CD006625.
74. US Food and Drug Administration Information for healthcare professionals: conventional antipsychotics http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124830.htm June 16, 2008 (accessed Nov 10, 2014).
75. MF Mendez, JS Shapira, A McMurtray, E Licht Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia Am J Geriatr Psychiatry 15 2007 84 87
76. AL Boxer, DS Knopman, DI Kaufer et al. Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial Lancet Neurol 12 2013 149 156
77. DW Sanders, SK Kaufman, SL DeVos et al. Distinct tau prion strains propagate in cells and mice and define different tauopathies Neuron 82 2014 1271 1288
78. K Yanamandra, N Kfoury, H Jiang et al. Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo Neuron 80 2013 402 414
79. CM Wischik, CR Harrington, JM Storey Tau-aggregation inhibitor therapy for Alzheimer's disease Biochem Pharmacol 88 2014 529 539
80. C Lagier-Tourenne, M Baughn, F Rigo et al. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration Proc Natl Acad Sci USA 110 2013 E4530 E4539
81. SL DeVos, DK Goncharoff, G Chen et al. Antisense reduction of tau in adult mice protects against seizures J Neurosci 33 2013 12887 12897
82. B Cenik, CF Sephton, CM Dewey et al. Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia J Biol Chem 286 2011 16101 16108
83. A Capell, S Liebscher, K Fellerer et al. Rescue of progranulin deficiency associated with frontotemporal lobar degeneration by alkalizing reagents and inhibition of vacuolar ATPase J Neurosci 31 2011 1885 1894